Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV)

NCT04535999 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Secukinumab Auto-Injector

Sponsor

University of Pennsylvania

Collaborators

[object Object]